Leukemoid Reaction in a Case of Chronic Cholecystitis With Focal Mild Acute Inflammation
DOI:
https://doi.org/10.33165/rmj.2021.44.3.250706Keywords:
Cholecystitis, Leukemoid reaction, White blood cellAbstract
Leukemoid reaction is a rare condition of marked increase of the white blood cells (WBC) in the peripheral blood, mostly more than 50 × 109/L. Although its most common cause is infection, acute or chronic cholecystitis has been hardly mentioned. This report aimed to present the leukemoid reaction found in a Thai who had chronic cholecystitis with focal acute inflammation. A 74-year-old woman had low-graded fever and generalized vague abdominal discomfort for 2 days. The physical examination showed the body temperature 37.7 °C and unremarkable abdominal signs. Her blood tests showed: hemoglobin 9.0 g/L, WBC 52.48 × 109/L, neutrophil 91%, band form 1%, platelet 434 × 109/L, and alkaline phosphatase (ALP) 290 U/L. The blood cultures yielded no growth. The computed tomography of the abdomen revealed 2 stones in the common bile duct (CBD) causing obstruction; the gall bladder (GB) showed mild dilatation with thin wall containing multiple small gall stones; no pericholecystic fluid and normal size of spleen. She promptly underwent operative cholecystectomy, CBD choledochoscopy, stones removal and T-tube choledochostomy. Along with the surgery, intravenous ertapenem was also administered. The pathology of the gall bladder was chronic cholecystitis with focal mild acute inflammation. With these therapies, fever daily decreased and finally disappeared within 5 days meanwhile the WBC count also gradually diminished every day till 8.04 × 109/L within 7 days. The WBC count was still normal one month later. The diagnosis of leukemoid reaction was concluded and it was presumably be associated with chronic calculous cholecystitis with focal acute inflammation although the BCR-ABL translocation had never been explored.
References
Karakonstantis S, Koulouridi M, Pitsillos K, et al. A prospective study of hospitalized patients with leukemoid reaction; causes, prognosis and value of manual peripheral smear review. Rom J Intern Med. 2019;57(3):241-247. doi:10.2478/rjim-2019-0006
Abukhiran IA, Jasser J, Syrbu S. Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours. J Clin Pathol. 2020;73(6):310-313. doi:10.1136/jclinpath-2019-206340
Potasman I, Grupper M. Leukemoid reaction: spectrum and prognosis of 173 adult patients. Clin Infect Dis. 2013;57(11):e177-e181. doi:10.1093/cid/cit562
Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H. An update of the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med. 2006;17(6):394-398. doi:10.1016/j.ejim.2006.04.004
Gonchar MO, Ishchenko TB, Koval VA. Main features of leukemoid reactions in children. Inter Collegas. 2016;3(1):8-12. Accessed May 5, 2021. https://inter.knmu.edu.ua/article/view/105/92/
Kapil M, Sareen R, Gupta GN. Leukemoid reaction-An update. Clin Pathol. 2019;3(1):000116. doi:10.23880/cprj-16000116
Rongnoparat C, Panpanit R. Hemolytic uremic syndrome associated with shigellosis: report of two cases. Southeast Asian J Trop Med Public Health. 1987;18(2):226-228.
Granatowicz A, Piatek CI, Moschiano E, El-Hemaidi I. Armitage JD, Akhtari M. An overview and update of chronic myeloid leukemia for primary care physicians. Korean J Fam Med. 2015;36(5):197-202. doi:10.4082/kjfm.2015.36.5.197
Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. Am J Hematol. 2018;93(3):442-459. doi:10.1002/ajh.25011
ARUP Consult. Chronic Myelogenous Leukemia - CML. August 25, 2020. Accessed May 5, 2021. https://arupconsult.com/content/chronic-myelogenous-leukemia
Zafar MN, Navid-ul-Haq, Qureshi SJ, Qureshi H. Differential leucocyte alkaline phosphatase activity (LAPA) in chronic myeloid leukaemia (CML) and myeloid leukemoid reaction (MLR). J Pak Med Assoc. 1984;34(5):114-116.
Van Etten RA. Clinical manifestations and diagnosis of chronic myeloid leukemia. UpToDate. Updated July 29, 2020. Accessed May 5, 2021. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-chronic-myeloid-leukemia
Ross TS, Mgbemena VE. Re-evaluating the role of BCR/ABL in chronic myeloid leukemia. Mol Cell Oncol. 2014;1(3):e963450. doi:10.4161/23723548.2014.963450
Fausel C. Targeted chronic myeloid leukemia therapy: seeking a cure. J Manag Care Pharm. 2007;13(8 Suppl A):8-12. doi:10.18553/jmcp.2007.13.s8-a.8
Reilly JT. Chronic neutrophilic leukaemia: a distinct clinical entity? Br J Haematol. 2002;116(1):10-18. doi:10.1046/j.1365-2141.2002.03234.x
Böhm J, Kock S, Schaefer HE, Fisch P. Evidence of clonality in chronic neutrophilic leukaemia. J Clin Pathol. 2003;56(4):292-295. doi:10.1136/jcp.56.4.292
Szuber N, Tefferi A. Chronic neutrophilic leukemia: new science and new diagnostic criteria. Blood Cancer J. 2018;8(2):19. doi:10.1038/s41408-018-0049-8
Patel AB, Pettijohn EM, Abedin SM, Raps E, Deininger MW. Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommendations. Blood Adv. 2019;3(7):952-955. doi:10.1182/bloodadvances.2019032300
Lee S, Chung CW, Ko KH, Kwon SW. Risk factors for the clinical course of cholecystitis in patients who undergo cholecystectomy. Korean J Hepatobiliary Pancreat Surg. 2011;15(3):164-170. doi:10.14701/kjhbps.2011.15.3.164
Temizi A, Özdemir Y, Aslan A, et al. Role of complete blood counts parameters in diagnosis of acute cholecystitis. Acta Medica Mediterranea. 2017;33:411-416. doi:10.19193/0393-6384_2017_3_060
Arer İM, Yabanoğlu H, Çalışkan K. Can red cell distribution width be used as a predictor of acute cholecystitis? Turk J Surg. 2017;33(2):76-79. doi:10.5152/turkjsurg.2017.3392
Jones MW, Gnanapandithan K, Panneerselvam D, Ferguson T. Chronic Cholecystitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. Updated March 26, 2021. Accessed May 5, 2021. https://www.ncbi.nlm.nih.gov/books/NBK470236/
Asiltürk Lülleci Z, Başyiğit S, Pirinççi Sapmaz F, et al. Comparison of ultrasonographic and laboratory findings of acute cholecystitis between elderly and nonelderly patients. Turk J Med Sci. 2016;46(5):1428-1433. doi:10.3906/sag-1507-13
Nidimusili AJ, Alraies MC, Eisa N, Alraiyes AH, Shaheen K. Leukocytosis of unknown origin: gangrenous cholecystitis. Case Rep Med. 2013;2013:418014. doi:10.1155/2013/418014
Cooper C. Fever and leuohkocytosis in acute cholecystitis. J Natl Med Assoc. 1987;79(9):911-912.
Gruber PJ, Silverman RA, Gottesfeld S, Flaster E. Presence of fever and leukocytosis in acute cholecystitis. Ann Emerg Med. 1996;28(3):273-277. doi:10.1016/s0196-0644(96)70025-2